EB
The startup develops antibody therapeutics specifically targeting fibro-inflammatory diseases, utilizing a proprietary platform for the design and production of these biologics. This technology provides healthcare professionals with effective treatment options for patients suffering from conditions characterized by excessive inflammation and fibrosis.
Updated 2 months ago
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops antibody therapeutics specifically targeting fibro-inflammatory diseases, utilizing a proprietary platform for the design and production of these biologics. This technology provides healthcare professionals with effective treatment options for patients suffering from conditions characterized by excessive inflammation and fibrosis.